**
In the heart of Montreal, the Polytechnique Montréal’s biomedicine laboratory is at the forefront of Canada’s efforts to bolster its pandemic preparedness. Under the initiative known as Ramp Up, researchers are diligently working to enhance the country’s biomanufacturing capabilities, ensuring that Canada is better prepared for any future health crises. With the echoes of the COVID-19 pandemic still resonating, the lab’s activities aim to close significant gaps in vaccine production and public trust.
A New Era of Pandemic Preparedness
Within the sterile confines of the Polytechnique lab, researchers in pristine white coats meticulously extract samples of animal protein from vibrant orange cultures. This environment, where the latest scientific techniques meet urgent public health needs, is a testament to the lessons learned from the COVID-19 pandemic. Head researcher Gregory De Crescenzo stresses the importance of proactive measures, stating, “It’s not a matter of if, but when,” when discussing future pandemic threats.
Ramp Up, the federal programme that underpins this research, is a collaborative endeavour involving numerous Canadian institutions. It seeks to rectify the shortcomings revealed during the pandemic, particularly the fragmented approach among government, academia, and industry that hampered effective responses. De Crescenzo highlights that enhanced coordination and shared resources are essential for successful outcomes.
Bridging Gaps in Biomanufacturing
The lab’s work extends beyond mere research; it is about creating a robust infrastructure for vaccine and biomedical production. De Crescenzo notes that one of Ramp Up’s primary goals is to ensure that Canada does not repeat past mistakes, particularly regarding vaccine supply chains. Historically, the country struggled to produce vaccines at scale, relying heavily on imports.
Students and researchers engage with equipment that mirrors what is found in commercial laboratories. They grow cells in specialized tubes and preserve samples in industrial-grade freezers, preparing for the large-scale production of vital health solutions. In this setting, De Crescenzo likens their work to crafting recipes—each process is meticulously documented and scrutinised before being handed over to industrial partners for implementation.
The Role of Public Trust
Amidst the scientific innovations, the Polytechnique lab also recognises the pressing need to rebuild public trust in medicine, a task made more challenging by the surge of vaccine misinformation during the pandemic. De Crescenzo hopes that transparency in their research processes will foster a renewed confidence among the public.
Marie-Gael Tchummo, a master’s student involved in the Ramp Up project, reflects on her experiences addressing vaccine hesitancy within her community. Many of her peers were initially sceptical about the safety and efficacy of rapidly developed vaccines. Through open discussions about her research, Tchummo has worked to alleviate their concerns, echoing De Crescenzo’s sentiment that public engagement is crucial for the success of pandemic preparedness initiatives.
Collaborative Efforts Across Sectors
The need for a comprehensive and unified approach to pandemic preparedness is echoed by experts like Isaac Bogoch, an infectious disease specialist at the University of Toronto. He argues that successful responses to health crises require collaboration across all sectors of society. “It’s a whole of government and a whole of society response,” Bogoch emphasises, noting that no single laboratory can shoulder this responsibility alone.
The Ramp Up initiative, launched in 2024, partners with a variety of institutions, including Université Laval and Simon Fraser University, to address the pressing need for skilled workers in biomanufacturing. By 2029, Canada will require over 15,000 professionals in this field, highlighting the urgency of training and education within this sector.
Investment in the Future
The Canadian government has pledged substantial funding to enhance the nation’s pandemic response capabilities. Health Canada reports a commitment of $712 million towards upgrading biocontainment facilities and establishing research hubs at prominent universities. Additionally, since 2020, over $2.5 billion has been invested in vaccine development and biomanufacturing, including initiatives aimed at reinforcing supply chain resilience.
As part of these efforts, the federal agency is also preparing a new emergency response plan, set to be unveiled in 2027, aimed at improving coordination among various levels of government and international partners, alongside Indigenous communities. This forward-thinking strategy reflects an understanding that the next public health emergency is not a matter of if, but when.
Why it Matters
As Canada navigates the complexities of pandemic preparedness, the work at Polytechnique Montréal stands as a beacon of hope and innovation. By prioritising collaboration, transparency, and community engagement, the Ramp Up initiative not only addresses immediate health challenges but also lays the groundwork for a more resilient healthcare system. This proactive approach is essential not only for safeguarding public health but also for restoring faith in scientific advancement at a time when trust is crucial.
